Diet and nutritional factors in inflammatory bowel diseases

World Journal of Gastroenterology

Volumn 22, Issue 3, 2016, Pages 895-905

  Owczarek, Danuta ^a   Rodacki, Tomasz ^a   Domagała Rodacka, Renata ^a   Cibor, Dorota ^a   Mach, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Crohn's disease; Diet; Nutrition; Supplementation; Ulcerative colitis

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; LINOLEIC ACID; MONOSACCHARIDE; OLIGOSACCHARIDE; OMEGA 3 FATTY ACID; POLYOL; PROBIOTIC AGENT; RETINOL; SULFUR; VITAMIN D; ZINC; ANTIINFLAMMATORY AGENT; GASTROINTESTINAL AGENT;

ALCOHOL CONSUMPTION; CALCIUM DEFICIENCY; CARBOHYDRATE ANALYSIS; CHRONIC INFLAMMATION; CITRUS FRUIT; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; FAT INTAKE; FOLIC ACID DEFICIENCY; HIGH FIBER DIET; HUMAN; IMMUNE SYSTEM; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRON DEFICIENCY; MAGNESIUM DEFICIENCY; NUTRITIONAL PARAMETERS; REMISSION; RETINOL DEFICIENCY; REVIEW; SOCIAL LIFE; SUGAR INTAKE; VEGETARIAN DIET; VITAMIN DEFICIENCY; ZINC DEFICIENCY; ADVERSE EFFECTS; DIET; DIET THERAPY; DIETARY SUPPLEMENT; INFLAMMATORY BOWEL DISEASES; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; QUALITY OF LIFE; RISK FACTOR; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; DIET; DIETARY SUPPLEMENTS; GASTROINTESTINAL AGENTS; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; NUTRITIONAL STATUS; QUALITY OF LIFE; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84961326171     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i3.895     Document Type: Review

References (77)

1. Malaty HM, Hou JK, Thirumurthi S. Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States. Clin Exp Gastroenterol 2010; 3: 165-170 [PMID: 21694862 DOI: 10.2147/CEG.S14586]
2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet 2012; 380: 1606-1619 [PMID: 22914296 DOI: 10.1016/S0140-6736(12)60150-0]
3. Jakubowski A, Zagórowicz E, Kraszewska E, Bartnik W. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn 2014; 124: 180-190 [PMID: 24727650]
4. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-1605 [PMID: 22914295 DOI: 10.1016/S0140-6736(12)60026-9]
5. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52: 229-238 [PMID: 9578334]
6. Inflammatory bowel disease: A global perspective. World Gastroenterology Organisation Global Guidelines. June 2009. Available from: URL: http://www.medscape.com/index/ list-7515-2
7. Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Guéant-Rodriguez RM, Freling E, Collet-Fenetrier B, Williet N, Ziegler O, Bigard MA, Guéant JL, Peyrin-Biroulet L. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 66-72 [PMID: 22467242 DOI: 10.1002/ ibd.22965]
8. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-523; quiz 524 [PMID: 20068560 DOI: 10.1038/ajg.2009.727]
9. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104: 465-483; quiz 464, 484 [PMID: 19174807 DOI: 10.1038/ ajg.2008.168]
10. Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, Dias JA, Bronsky J, Braegger CP, Cucchiara S, de Ridder L, Fagerberg UL, Hussey S, Hugot JP, Kolacek S, Kolho KL, Lionetti P, Paerregaard A, Potapov A, Rintala R, Serban DE, Staiano A, Sweeny B, Veerman G, Veres G, Wilson DC, Ruemmele FM. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012; 55: 340-361 [PMID: 22773060]
11. National Institute for Health and Clinical Excellence: Guidance. Crohn's disease: Management in adults, children and young people. National Clinical Guideline Centre: October, 2012
12. Silva AFD, Schieferdecker MEM, Amarante HMBDS. Food intake in patients with inflammatory bowel disease. Arq Bras Cir Dig 2011; 24: 204-209
13. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014; 20: 91-99 [PMID: 24415861 DOI: 10.3748/wjg.v20.i1.91]
14. Jørgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. Active Crohn's disease is associated with low Vitamin D levels. J Crohns Colitis 2013; 7: e407-e413 [PMID: 23403039 DOI: 10.1016/j.crohns.2013.01.012]
15. Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, Eshee L, Mason D. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014; 59: 516-521 [PMID: 24897165 DOI: 10.1097/MPG.0000000000000449]
16. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-A pilot study. J Crohns Colitis 2009; 3: 8-14 [PMID: 21172242 DOI: 10.1016/ j.crohns.2008.09.004]
17. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: A systematic review of intervention studies in adult patients. Drugs 2012; 72: 803-823 [PMID: 22512365 DOI: 10.2165/11632710-000000000-00000]
18. Farrukh A, Mayberry JF. Is there a role for fish oil in inflammatory bowel disease? World J Clin Cases 2014; 2: 250-252 [PMID: 25032198 DOI: 10.12998/wjcc.v2.i7.250]
19. Basson A. Nutrition management in the adult patient with Crohn's disease. S Afr J Clin Nutr 2012; 25: 164-172
20. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, Inaba Y, Miyake Y, Sasaki S, Okamoto K, Kobashi G, Washio M, Yokoyama T, Date C, Tanaka H. Dietary risk factors for inflammatory bowel disease: A multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-163 [PMID: 15677909]
21. Kanai T, Matsuoka K, Naganuma M, Hayashi A, Hisamatsu T. Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods. Korean J Intern Med 2014; 29: 409-415 [PMID: 25045286 DOI: 10.3904/kjim.2014.29.4.409]
22. Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis 2007; 13: 573-579 [PMID: 17345609]
23. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: A meta-analysis. Mayo Clin Proc 2006; 81: 1462-1471 [PMID: 17120402]
24. Jones DT, Osterman MT, Bewtra M, Lewis JD. Passive smoking and inflammatory bowel disease: A meta-analysis. Am J Gastroenterol 2008; 103: 2382-2393 [PMID: 18844625 DOI: 10.1111/j.1572-024]
25. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: A systematic review with meta-analysis. Am J Clin Nutr 2004; 80: 1342-1352 [PMID: 15531685]
26. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754-760 [PMID: 9245929]
27. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ, Stockbrügger RW. Modern life' in the epidemiology of inflammatory bowel disease: A case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243-249 [PMID: 9585029]
28. Chan SS, Luben R, van Schaik F, Oldenburg B, Bueno-de-Mesquita HB, Hallmans G, Karling P, Lindgren S, Grip O, Key T, Crowe FL, Bergmann MM, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Hart AR. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2014; 20: 2013-2021 [PMID: 25265262 DOI: 10.1097/MIB.0000000000000168]
29. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Longterm intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014; 63: 776-784 [PMID: 23828881 DOI: 10.1136/ gutjnl-2013-305304]
30. Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, Hallmans G, Palmqvist R, Sjodin H, Hagglund G, Berglund G, Lindgren S, Grip O, Palli D, Day NE, Khaw KT, Bingham S, Riboli E, Kennedy H, Hart A. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-1611 [PMID: 19628674 DOI: 10.1136/ gut.2008.169078]
31. de Silva PS, Luben R, Shrestha SS, Khaw KT, Hart AR. Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: A prospective cohort study using 7-day food diaries. Eur J Gastroenterol Hepatol 2014; 26: 11-18 [PMID: 24216567 DOI: 10.1097/MEG.0b013e328365c372]
32. John S, Luben R, Shrestha SS, Welch A, Khaw KT, Hart AR. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: A UK prospective cohort study. Eur J Gastroenterol Hepatol 2010; 22: 602-606 [PMID: 20216220 DOI: 10.1097/MEG.0b013e3283352d05]
33. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-977 [PMID: 23912083 DOI: 10.1053/j.gastro.2013.07.050]
34. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C, Chotard V, Budai B, Law L, Levy E, Seidman EG. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102: 2016-2025 [PMID: 17617201]
35. Rossi T, Gallo C, Bassani B, Canali S, Albini A, Bruno A. Drink your prevention: beverages with cancer preventive phytochemicals. Pol Arch Med Wewn 2014; 124: 713-722 [PMID: 25490889]
36. El-Tawil AM. Epidemiology and inflammatory bowel diseases. World J Gastroenterol 2013; 19: 1505-1507 [PMID: 23539486 DOI: 10.3748/wjg.v19.i10.1505]
37. Han DY, Fraser AG, Dryland P, Ferguson LR. Environmental factors in the development of chronic inflammation: A case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res 2010; 690: 116-122 [PMID: 19751746 DOI: 10.1016/ j.mrfmmm.2009.09.002]
38. Bishop J, Lemberg DA, Day A. Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther 2014; 5: 1-13 [PMID: 24729736 DOI: 10.2147/AHMT.S37956]
39. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007; 26: 795-806 [PMID: 17767463]
40. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007; (1): CD000542 [PMID: 17253452]
41. Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: A randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4: 744-753 [PMID: 16682258]
42. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007; (3): CD005984 [PMID: 17636816]
43. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 2004; 53: 1479-1484 [PMID: 15361498]
44. Fernández-Bañares F, Hinojosa J, Sánchez-Lombraña JL, Navarro E, Martínez-Salmerón JF, García-Pugés A, González-Huix F, Riera J, González-Lara V, Domínguez-Abascal F, Giné JJ, Moles J, Gomollón F, Gassull MA. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol 1999; 94: 427-433 [PMID: 10022641]
45. Hallert C, Kaldma M, Petersson BG. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scand J Gastroenterol 1991; 26: 747-750 [PMID: 1654592]
46. Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: A systematic review of randomized controlled trials. Inflamm Bowel Dis 2014; 20: 576-586 [PMID: 24445775]
47. Brotherton CS, Taylor AG, Bourguignon C, Anderson JG. A high-fiber diet may improve bowel function and healthrelated quality of life in patients with Crohn disease. Gastroenterol Nurs 2014; 37: 206-216 [PMID: 24871666 DOI: 10.1097/ SGA.0000000000000047]
48. Kanauchi O, Iwanaga T, Andoh A, Araki Y, Nakamura T, Mitsuyama K, Suzuki A, Hibi T, Bamba T. Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J Gastroenterol Hepatol 2001; 16: 160-168 [PMID: 11207896]
49. Bamba T, Kanauchi O, Andoh A, Fujiyama Y. A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis. J Gastroenterol Hepatol 2002; 17: 818-824 [PMID: 12164955]
50. Hanai H, Kanauchi O, Mitsuyama K, Andoh A, Takeuchi K, Takayuki I, Araki Y, Fujiyama Y, Toyonaga A, Sata M, Kojima A, Fukuda M, Bamba T. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med 2004; 13: 643-647 [PMID: 15067363]
51. Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol 2010; 44: 223-228 [PMID: 20682190 DOI: 10.1016/j.alcohol.2009.10.019]
52. Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report. Nutr J 2014; 13: 5[PMID: 24428901 DOI: 10.1186/1475-2891-13-5]
53. Suskind DL, Wahbeh G, Gregory N, Vendettuoli H, Christie D. Nutritional therapy in pediatric Crohn disease: The specific carbohydrate diet. J Pediatr Gastroenterol Nutr 2014; 58: 87-91 [PMID: 24048168 DOI: 10.1097/MPG.0000000000000103]
54. Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H, Fujiwara K, Imai H. Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol 2010; 16: 2484-2495 [PMID: 20503448 DOI: 10.3748/wjg.v16. i20.2484]
55. Donnellan CF, Yann LH, Lal S. Nutritional management of Crohn' s disease. Therap Adv Gastroenterol 2013; 6: 231-242 [PMID: 23634187 DOI: 10.1177/1756283X13477715]
56. Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne) 2014; 1: 58 [PMID: 25646159 DOI: 10.3389/fmed.2014.00058]
57. Kaniewska M, Bartnik W, Gonciarz M, Kłopocka M, Linke K, Małecka-Panas E, Radwan P, Reguła J, Rydzewska G. Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations. Prz Gastroenterol 2014; 9: 259-263 [PMID: 25395998 DOI: 10.5114/pg.2014.46159]
58. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol 1994; 89: 872-877 [PMID: 8198097]
59. Strisciuglio C, Giannetti E, Martinelli M, Sciorio E, Staiano A, Miele E. Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis? Acta Paediatr 2013; 102: e273-e278 [PMID: 23445275 DOI: 10.1111/apa.12215]
60. Gupta R, Makharia G, Khadgawat R, Yadav RK. Evaluation of lactose and milk intolerance, and bone mineral density in Indian patients with inflammatory bowel disease. Natl Med J India 2012; 25: 327-331 [PMID: 23998861]
61. Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, Payer J. Higher Vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 2014; 20: 15787-15796 [PMID: 25400464 DOI: 10.3748/wjg.v20.i42.15787]
62. Abraham BP, Prasad P, Malaty HM. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients. Dig Dis Sci 2014; 59: 1878-1884 [PMID: 24619280 DOI: 10.1007/s10620-014-3102-x]
63. Jørgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF. Clinical trial: Vitamin D3 treatment in Crohn's disease-A randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32: 377-383 [PMID: 20491740 DOI: 10.1111/j.1365-2036.2010.04355.x]
64. Pappa HM, Mitchell PD, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D, Quinn N, Lawton RC, Bronzwaer ME, Koenen M, Gordon CM. Maintenance of optimal Vitamin D status in children and adolescents with inflammatory bowel disease: A randomized clinical trial comparing two regimens. J Clin Endocrinol Metab 2014; 99: 3408-3417 [PMID: 24926949 DOI: 10.1210/ jc.2013-4218]
65. Dadaei T, Safapoor MH, Asadzadeh Aghdaei H, Balaii H, Pourhoseingholi MA, Naderi N, Zojaji H, Azimzadeh P, Mohammadi P, Zali MR. Effect of Vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients. Gastroenterol Hepatol Bed Bench 2015; 8: 49-55 [PMID: 25584176]
66. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Higher plasma Vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 1136-1142 [PMID: 24641590 DOI: 10.1111/apt.12706]
67. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Association between reduced plasma 25-hydroxy Vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014; 12: 821-827 [PMID: 24161349 DOI: 10.1016/j.cgh.2013.10.011]
68. Kunachowicz H, Nadolna I, Przygoda B, Iwanow K. Tabele składu i wartos̈ci odzywczej zywnos̈ci. Wydawnictwo Lekarskie PZWL: Warszawa, 2005
69. Guandalini S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne) 2014; 1: 23 [PMID: 25593899 DOI: 10.3389/ fmed.2014.00023]
70. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn' s disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis 2014; 20: 21-35 [PMID: 24280877 DOI: 10.1097/01.MIB.0000437495.30052]
71. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104: 437-443 [PMID: 19174792 DOI: 10.1038/ajg.2008.118]
72. Bourreille A, Cadiot G, Le Dreau G, Laharie D, Beaugerie L, Dupas JL, Marteau P, Rampal P, Moyse D, Saleh A, Le Guern ME, Galmiche JP. Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol 2013; 11: 982-987 [PMID: 23466709 DOI: 10.1016/j.cgh.2013.02.021]
73. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45: 1462-1464 [PMID: 10961730]
74. Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-698 [PMID: 12840682]
75. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000; 31: 453-457 [PMID: 11045848]
76. Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005; 11: 833-839 [PMID: 16116318]
77. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 405-409 [PMID: 12171964]